MFN2 and cervical carcinoma: During the treatment, the volume of xenografted cervix carcinomas treated with Adv-mfn2 increased slowly, whereas the volume of the tumors treated with Adv-control increased faster than the Adv-mfn2 group (Fig. 3a, b).